Oncology status update: Difference between revisions
Jump to navigation
Jump to search
Hudakarman (talk | contribs) |
Hudakarman (talk | contribs) |
||
| Line 437: | Line 437: | ||
|- | |- | ||
| rowspan="51" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Oncology | | rowspan="51" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Oncology | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Acute lymphoblastic leukemia | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 445: | Line 445: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Acute myeloid leukemia | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 453: | Line 453: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Acute promyelocytic leukemia | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 462: | Line 462: | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Adult T-cell leukemia | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 882: | Line 882: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Anaplastic large cell lymphoma | ||
Anaplastic large cell lymphoma | |||
Burkitt's lymphoma | Burkitt's lymphoma | ||
Chronic lymphocytic leukemia | Chronic lymphocytic leukemia | ||
Revision as of 05:26, 3 July 2020
System leader: Farima Kahe, M.D.
List of Chapters Requiring Content
| Category | Chapters that need content | Assignment Status | Scholar's name | Coach name | Completion Status | Review status | Reviewer name |
|---|---|---|---|---|---|---|---|
| Oncology | |||||||
In progress chapters
| Category | Chapters that need content | Assignment Status | Scholar's name | Coach name | Completion Status | Review status | Reviewer name |
|---|---|---|---|---|---|---|---|
| Oncology | |||||||
Completed chapters
| Category | Chapters that need content | Assignment Status | Scholar's name | Coach name | Completion Status | Review status | Reviewer name |
|---|---|---|---|---|---|---|---|
| Oncology | Acute lymphoblastic leukemia | ||||||
| Acute myeloid leukemia | |||||||
| Acute promyelocytic leukemia | |||||||
| Adult T-cell leukemia | |||||||
| Anaplastic large cell lymphoma
Burkitt's lymphoma Chronic lymphocytic leukemia Chronic myelogenous leukemia Chronic neutrophilic leukemia Diffuse large B cell lymphoma Follicular lymphoma Hairy cell leukemia Hodgkin's lymphoma Leukemia (LP) Leukocytosis (SP) Hemophilia Lymphadenopathy Lymphangioma Lymphangiomyomatosis (SP) Lymphangiosarcoma (SP) Lymphoma (LP) Lymphomatoid granulomatosis Mast cell leukemia Mast cell tumor Multiple myeloma Myelodysplastic syndrome |